Status:
COMPLETED
Effects of Glutamine in Ischemic Heart Disease Patients Following Cardiopulmonary Bypass
Lead Sponsor:
Meshalkin Research Institute of Pathology of Circulation
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether perioperative glutamine administration possess protective properties on internal organs (heart and gut) in patients with coronary atherosclerosis, ope...
Eligibility Criteria
Inclusion
- Adult patients with coronary artery disease operated on under cardiopulmonary bypass
Exclusion
- Ejection fraction\<40%
- Viral hepatitis
- Liver cirrhosis
- Cholecystitis
- Pancreatitis
- Chronic severe gastrointestinal disease
- Surgery on gastrointestinal tract in patient's medical history
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01478126
Start Date
January 1 2012
End Date
September 1 2013
Last Update
November 1 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
State Research Institute of Circulation Pathology
Novosibirsk, Russia